TABLE 1.
Plasma rimonabant concentrations following a single 20 or 40 mg rimonabant dose in eight daily cannabis smokers.
Rimonabant concentration (ng/mL)
| ||||
---|---|---|---|---|
Subject | Dose | Time of sample
|
||
11:30 | 15:00 | 22:00 | ||
A | 20 | 89.5 | 76.2 | 49.1 |
B | 20 | 181 | 67.0 | 23.6 |
C | 20 | 71.8 | 33.2 | 10.7 |
D | 20 | 172 | 54.7 | 27.6 |
E | 20 | 168 | 61.4 | 44.8 |
F | 40 | 378 | 111 | 45.0 |
G | 40 | 143 | 67.7 | 23.5 |
H | 40 | 187 | 57.2 | 30.3 |
Note: Daily cannabis smokers were administered Δ9-tetrahydrocannabinol (THC) 20 mg orally every 4–8 hours over 8 days (120 mg THC/day for last 3 days prior to rimonabant). At 9:30 on the ninth day, five subjects received rimonabant 20 mg and three subjects received rimonabant 40 mg concurrently with the last dose of THC.